Skip to content

Released Feb 24, 2015, before the open

10-K filed Mar 12, 2015, 71 days after period end · 0001144204-15-015700

Q4 2014 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income-$6.23MderivedN/M vs Q4 2013N/M vs Q3 2014
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$6,284,717N/M
Operating Cash Flowderived-$3,592,920—
Free Cash Flowderived-$3,722,357N/M

What the release said

The release

Same quarter

MetricQ4 2014derived from reported figuresQ4 2013derived from reported figuresQ4 2012Q4 2011
Net Income-$6.23M-$6.05M-$3.79M-$18.86M
EPS Diluted——-$0.29-$1.52

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR